Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,774 | 47,660 | 54,073 | 59,410 | 8,698 |
| TOTAL | $40,220 | $48,080 | $54,706 | $60,313 | $9,047 |
| Non-Current Assets | |||||
| PPE Net | 140 | 169 | 198 | 228 | 270 |
| Other Non-Current Assets | 1,833 | 1,990 | 2,136 | 2,111 | 2,261 |
| TOTAL | $1,973 | $2,159 | $2,334 | $2,339 | $2,531 |
| Total Assets | $42,193 | $50,239 | $57,040 | $62,652 | $11,578 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,808 | 3,725 | 3,820 | 2,838 | 2,220 |
| Accrued Expenses | 3,563 | 6,004 | 4,477 | 3,059 | 3,886 |
| TOTAL | $8,087 | $10,433 | $8,989 | $6,577 | $6,775 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 977 | 1,557 | 2,178 | 2,675 | 2,657 |
| TOTAL | $977 | $1,557 | $2,178 | $2,675 | $2,657 |
| Total Liabilities | $9,064 | $11,990 | $11,167 | $9,252 | $9,432 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,506 | 9,491 | 9,498 | 9,498 | 6,132 |
| Common Shares | 95 | 95 | 95 | 95 | 49 |
| Retained earnings | -219,952 | -214,491 | -206,486 | -198,553 | -194,733 |
| TOTAL | $33,129 | $38,249 | $45,873 | $53,400 | $2,146 |
| Total Liabilities And Equity | $42,193 | $50,239 | $57,040 | $62,652 | $11,578 |